Skip to content

DNTH

Dianthus Therapeutics, Inc.

Stock

$88.21−0.11 (−0.12%)Close Oct 2, 2026

Shareholders' equity, 2025
$493M
YoY, 2025
+40.0%
5-year CAGR
+27.9%

Shareholders' equity

Shareholders' equity by fiscal year

PeriodEquityYoY
2025$493M+40.0%
2024$352M+108.7%
2023$169M—
2022−$44M—
2021$173M+20.0%
2020$144M+1.9%
2019$141M−3.1%
2018$146M—
2017−$42M—
2016−$8.9M—